Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Biotech
Keros mulls sale, strengthens defense against activist investors
Keros Therapeutics is considering whether it needs to find a buyer, while strengthening its stockholder rights as activist investors circle.
James Waldron
Apr 10, 2025 8:44am
Arch-backed tRNA biotech shutters after viewing preclinical data
Mar 18, 2025 10:15am
Takeda's oncology execs sharpen focus after restructuring
Mar 13, 2025 10:59am
Takeda's $300M bet on Protagonist's blood cancer drug pays off
Mar 3, 2025 8:45am
Takeda fronts $46M for 2nd small molecule collab with BridGene
Feb 25, 2025 8:00am
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Jan 31, 2025 8:30am